# A Study of E7080 in Subjects With Advanced Thyroid Cancer

> **NCT01728623** · PHASE2 · COMPLETED · sponsor: **Eisai Co., Ltd.** · enrollment: 51 (actual)

## Conditions studied

- Thyroid Cancer

## Interventions

- **DRUG:** E7080 capsule

## Key facts

- **NCT ID:** NCT01728623
- **Lead sponsor:** Eisai Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09-03
- **Primary completion:** 2015-07-09
- **Final completion:** 2015-10-01
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2020-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01728623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01728623, "A Study of E7080 in Subjects With Advanced Thyroid Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01728623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*